SCHEMBL6235655

SCHEMBL6235655

COc1ccc(S(=O)(=O)NC2Cc3ccccc3C2)cc1N1CCNCC1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 20/20 0.63
HTR7 P34969 1/20 0.57
HTR4 Q13639 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6237285 0.87 PDE4A (0.64) HTR6HTR7HTR4
SCHEMBL6235673 0.86 PDE4A (0.62) HTR6
SCHEMBL6234462 0.86 PDE4A (0.62) HTR6
SCHEMBL6235886 0.85 HTR6 (0.60) HTR6HTR7HTR4
Hydrochloric Acid SCHEMBL6237229 0.85 PDE4A (0.61) HTR6HTR7HTR4
SCHEMBL6236510 0.84 PDE4A (0.69) HTR6
Hydrochloric Acid SCHEMBL6234448 0.83 PDE4A (0.68) HTR6
SCHEMBL6233388 0.82 HTR6 (0.57) HTR6HTR7HTR4
SCHEMBL6236589 0.81 HTR6 (0.56) HTR6HTR7HTR4
SCHEMBL7413456 0.81 PDE4A (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049679-B1 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2005-06-01 EP claimed
EP-1049679-A2 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2000-11-08 EP claimed
WO-1999037623-A2 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1999-07-29 WO claimed
EP-1049679-B1 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2005-06-01 EP disclosed
US-6548504-B1 Compounds SMITHKLINE BEECHAM P.L.C. (GB) 2003-04-15 US disclosed
EP-1049679-A2 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2000-11-08 EP disclosed
WO-1999037623-A2 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1999-07-29 WO disclosed